In a recent drug safety advisory, the Indian Pharmacopoeia Commission (IPC) advised consumers and healthcare providers to keep an eye out for any negative side effects from the painkiller Meftal, which is frequently prescribed for rheumatoid arthritis and menstrual cramps.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/8rGszHN
via
IPC issues alert against adverse reactions of painkiller Meftal
December 07, 2023
0
Tags
-min.png)